Arcus Biosciences Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Arcus Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $41. The average 1-year stock price forecast is 135.23% higher than the current stock price, while the lowest is $23 (+31.96%) and the highest is $50 (+186.86%).

Price Target: $41 (+135.23%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$23	$41	$45	$50
Change	+31.96%	+135.23%	+158.18%	+186.86%

Analyst Ratings

The average analyst rating for Arcus Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26	Nov '26
Strong Buy	10	10	10	11	12	12
Buy	0	0	0	0	1	1
Hold	3	3	3	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	13	13	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Priyanka Grover J.P. Morgan	J.P. Morgan	Buy Reiterates $41 → $40	Buy	Reiterates	$41 → $40	+129.49%	Nov 9, 2026
Terence Flynn Morgan Stanley	Morgan Stanley	Hold Reiterates $23	Hold	Reiterates	$23	+31.96%	Nov 6, 2026
Unknown Analyst Leerink Partners No rating	Leerink Partners	Buy Maintains $46 → $49	Buy	Maintains	$46 → $49	+181.12%	Nov 5, 2026
Robert Driscoll Wedbush	Wedbush	Buy Reiterates $49 → $45	Buy	Reiterates	$49 → $45	+158.18%	Nov 5, 2026
Yigal Nochomovitz Citi	Citi	Buy Maintains $50	Buy	Maintains	$50	+186.86%	Nov 5, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

72.40M

from 247.00M

-70.69%

from 247.00M

Revenue Next Year

46.03M

from 72.40M

-36.42%

from 72.40M

EPS This Year

-3.45

from -3.29

EPS Next Year

-3.19

from -3.45

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	383.00M	112.00M	117.00M	258.00M	247.00M	72.40M
Revenue Growth	391.03%	-70.76%	4.46%	120.51%	-4.26%	-70.69%
Operating Income	54.00M	-280.00M	-340.00M	-310.00M	-386.00M	-477.51M
Net Income	53.00M	-267.00M	-307.00M	-283.00M	-353.00M	-461.96M
EPS	-	-	-	-	-3.29	-3.45
Free Cash Flow	-	-	-	-	-484.00M	-449.00M
No. Analysts	-	-	-	-	-	13

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	81.5M
Avg	72.4M
Low	67.0M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-67.0%
Avg	-70.7%
Low	-72.9%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-3.03
Avg	-3.45
Low	-3.75

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-